SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031415
Filing Date
2022-11-10
Accepted
2022-11-10 16:47:06
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1651957
2 ex31-1.htm EX-31.1 18951
3 ex31-2.htm EX-31.2 18822
4 ex32-1.htm EX-32.1 8727
  Complete submission text file 0001493152-22-031415.txt   9412843

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20220930.xsd EX-101.SCH 81980
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocx-20220930_cal.xml EX-101.CAL 82030
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocx-20220930_def.xml EX-101.DEF 411634
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20220930_lab.xml EX-101.LAB 607877
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20220930_pre.xml EX-101.PRE 512898
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1620165
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 221378109
SIC: 2835 In Vitro & In Vivo Diagnostic Substances